AGIO

#1742
Agios Pharmaceuticals, Inc. - Common Stock
29.4 0 USD
-3.35%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
29.38
29.40
Faixa anual
0.28
45.99
Mudança diária
-3.35%
Mudança mensal
+4.74%
Mudança em 6 meses
+3.12%
Mudança anual
-32.24%
Fechamento anterior
30.4 2
Open
29.3 8
Mínimo
29.3 8
High
29.4 0
Volume
121
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor 202020212022202320242025 TTM

Agios Pharmaceuticals, Inc. - Common Stock

Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.

Notícias